CAS-AM

Certificate of Advanced Studies in Antithrombotic Management. Organized from @MaastrichtUMC. Endorsed by @isth, @EMLTDthrombosis, @attendECTH and @SISETonline.

[Saskia Middeldorp @MiddeldorpS]

Interesting ex-vivo data suggesting that dabigatran may be an interesting drug to study in patients with #ALL #ASH22 ⁦@LeaderAvi⁩

[CAS-AM @CAS_AM_eu]

Exciting day in training the new antithrombotic management experts: Portfolio Discussions with faculty. More at https://t.co/33ZmBLcVRN

[CAS-AM @CAS_AM_eu]

Fantastic combined lecture by Harry Büller and Rupert Bauersachs on the medical need of FXI(a) inhibition in venous and arterial #thrombosis: do we believe in the holy grail?

[CAS-AM @CAS_AM_eu]

Start of the 2nd day at CAS-AM with an interesting program on venous thrombosis and thrombosis at unusual sites. Kick-off by case-discussion guided by @Erik_Klok_MD and Rupert Bauersachs #thrombosis #antithrombosismanagement #maastricht

[CAS-AM @CAS_AM_eu]

CAS-AM: Shaping the Future of Thrombosis Care

After a long summer in which the participants completed their portfolio, it’s time for the second CAS-AM course week. The first day focused on venous thrombosis, PE, and PTS. #thrombosis #venous #antithrombosis #maastricht

[CAS-AM @CAS_AM_eu]

Last presentation of the 1st course week on training the new leaders in antithrombotic management. Carlo Patrono presenting on "Mechanistic insight into how #aspirin prevents #atherothrombosis". Participants will workon their portfolio and be back in November for week 2.

[Henri Spronk @HSpronk]

Day 4 morning session at @CAS_AM_eu with a fantastic interactive lecture on “Management of thrombosis during pregnancy” by @MiddeldorpS in which she goes back to the discussion on the complicated case earlier today. #thrombosis in #pregnancy

[CAS-AM @CAS_AM_eu]

Update from day 3 afternoon session with the shared key-note "Antiphospholipid syndrome" by Rolf Urbanus and Stéphane Zuily (@szuily), including the must-read paper by Miyakis on international consensus in APS classification: https://t.co/UtedBaIf5Z #thrombosis #aps

[Saskia Middeldorp @MiddeldorpS]

Great meeting shaping future leaders in #Thrombosis. @CAS_AM_eu with @JennekeLeentje1 and her group discussing a complicated case of #thrombosis in #pregnancy

[CAS-AM @CAS_AM_eu]

It’s time to dive into “Coagulopathy in ICU” with a great lead-in lecture by @nicola_curry and @Sa_Eichinger_MD!
#thrombosis #antithromboticmanagement #intensivecareunit

[CAS-AM @CAS_AM_eu]

Should have added @Matteocandeloro to the list of presenters...

[CAS-AM @CAS_AM_eu]

Well prepared and lively discussions: the participants presented the problems and potential solutions for the 2nd case on "Patient with high risk of #atherothrombosis and #bleeding. Presentations by @MoaSimonsson @JennekeLeentje1 @obeidallax amongst others.

[CAS-AM @CAS_AM_eu]

The third day started with an interesting discussion about antiplatelet therapy which is now followed by the lead-out lecture “The role of bleeding in patients with coronary artery syndrome” given by Jur ten Berg. #antiplatelet #cardiology @antoniuszkh @MaastrichtUMC

[CAS-AM @CAS_AM_eu]

To fail or not to fail! During a tasty diner Stéphane Zully (@szuily), Gemma Vilahur, @HSpronk and Harry Buller shared their biggest career failures and the lessons they learned from this. One lesson learned: plan, do research, publish, communicate.

[CAS-AM @CAS_AM_eu]

After some great discussion on venous #thrombosis, we are moving on to #atherothrombosis by an opening lecture on #platelet function testing given by Thomas Lecompte.

[Henri Spronk @HSpronk]

Nick van Es explaining his personal approach in establishing new collaborations in #cancer and #thrombosis research at @CAS_AM_eu. Main message: talk to your colleagues.

[CAS-AM @CAS_AM_eu]

Showing the impressive data on increased arterial and venous #thrombosis risk for cancer patients: data from the must-read paper by Grilz et al. https://t.co/KWiyxq9QYN

[CAS-AM @CAS_AM_eu]

After an interesting post-discussion on the 1st case, now the lead-out lecture "Cancer therapies and risk of thrombosis" by @Cihan_Ay_MD and Nick van Es. #thrombosis #cancer #antithromboticmanagement

[CAS-AM @CAS_AM_eu]

Starting the second day with a lively discussion on VTE and cancer. It is inspiring to see all the training attendees discussing their views and practices on treating PE.

[CAS-AM @CAS_AM_eu]

Bridging gaps for thrombosis care leadership: training the new leaders in thrombosis case. Introduction workshop on leadership by Katarzyna Czabanowska from @MaastrichtU #thrombosis #Leadership